Oncolytic Herpes Simplex Virus ICP47 Deletion Reverses Tumor Immune Evasion

Yangtze Medicine

doi 10.4236/ym.2018.24024

Full Text

Abstract

Available in

Date

January 1, 2018

Authors

Publisher

Scientific Research Publishing, Inc,

Related search

Immune Evasion by Herpes Simplex Viruses

English

Anti-Tumor Effect of Oncolytic Herpes Simplex Virus G47delta on Human Nasopharyngeal Carcinoma

Chinese Journal of Cancer

English

Treatment of Implantable NF2 Schwannoma Tumor Models With Oncolytic Herpes Simplex Virus G47Δ

Cancer Gene Therapy

Cancer Research

Molecular Medicine

Molecular Biology

English

Development of an Oncolytic Herpes Simplex Virus Using a Tumor-Specific HIF-responsive Promoter

Cancer Gene Therapy

Cancer Research

Molecular Medicine

Molecular Biology

English

Herpes Simplex Virus Type 1 Targets the MHC Class II Processing Pathway for Immune Evasion

Journal of Immunology

English

Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus

Cancer Gene Therapy

Cancer Research

Molecular Medicine

Molecular Biology

English

Tracheal Pseudo-Tumor Caused by Herpes Simplex Virus

Multidisciplinary Respiratory Medicine

Respiratory Medicine

English

Treatment of Human Hepatocellular Carcinoma by the Oncolytic Herpes Simplex Virus G47delta

Cancer Cell International

Cancer Research

English

A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer

English